Our team of experts brings you cancer-related?news, features, and survivor stories.
For the latest news about research we conduct and fund, see P站视频 Research News.
Published on: January 10, 2020
The US Food and Drug Administration (FDA) has approved Ayvakit (avapritinib) to treat people with advanced cases of gastrointestinal stromal tumor (GIST) that have a certain genetic mutation.